LKFT · Lakefront Biotherapeutics NV ADR
United States · RS rating 80 · As of 2026-11-03
| Price | 32.15 USD |
|---|---|
| 1-day change | +0.4% |
| RS rating (overall / 1M / 3M / 12M) | 80 / 80 / 91 / 52 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 36 / 48 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -99.3% |
| Distance from 52-week high | +7.2% |
| Market cap (USD) | $1.8B |